Lack of advanced models

Predictive models are in many cases not advanced and robust enough to be used in the reduction, refinement and/or replacement of the clinical trials required for the certification of new medical products.

Our goal:

Better models: develop more advanced models for the evaluation of safety and efficacy for both medicinal and medical device products that address specific Contexts of Use (CoUs), but at the same time enable a completely new class of models of disease with a similar pathogenesis.